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Sprouty1The tyrosine phosphatase Shp2 acts downstream of various growth factors, hormones or cytokine receptors.
Mutations of the Shp2 gene are associatedwith several human diseases. Here we have ablated Shp2 in the devel-
oping kidneys ofmice, using the ureteric bud epithelium-speciﬁcHoxb7/Cre.Mutantmice produced a phenotype
that is similar to mutations of the genes of the GDNF/Ret receptor system, that is: strongly reduced ureteric bud
branching and downregulation of the Ret target genes Etv4 and Etv5. Shp2mutant embryonic kidneys also dis-
played reduced cell proliferation at the branch tips and branching defects, which could not be overcome by
GDNF in organ culture. We also examined compound mutants of Shp2 and Sprouty1, which is an inhibitor of
receptor tyrosine kinase signaling in the kidney. Sprouty1 single mutants produce supernumerary ureteric
buds, which branch excessively. Sprouty1 mutants rescued branching deﬁcits in Ret−/− and GDNF−/− kidneys.
Sprouty1; Shp2 double mutants showed no rescue of kidney branching. Our data thus indicate an intricate inter-
play of Shp2 and Sprouty1 in signaling downstream of receptor tyrosine kinases during kidney development.
Apparently, Shp2mediates not only GDNF/Ret but also signaling by other receptor tyrosine kinases in branching
morphogenesis of the embryonic kidney.
© 2011 Elsevier Inc. All rights reserved.Introduction
Branching morphogenesis provides the basis for the generation of
complex tubular networks of epithelial tissues. Studies of the signal-
ing pathways that regulate branching morphogenesis have given
insights into mechanisms of numerous congenital diseases (Ichihara
et al., 2004). The development of the metanephric kidney initiates
when the ureteric bud emerges from the Wolfﬁan duct and invades
the metanephric mesenchyme at embryonic day (E)10.5. The ureteric
bud subsequently branches to form a tree-like structure that gives
rise to collecting ducts, pelvis and ureter. Mesenchyme-secreted
Glial Cell Line Derived Neurotrophic Factor (GDNF) activates the
receptor tyrosine kinase Ret in the ureteric bud epithelium. GDNF
binds to Ret in cooperation with the GDNF family receptor alpha-1
(GFRα-1) (Takahashi, 2001). Mice that are null mutants for GDNF, Ret
or GFRα-1 display renal agenesis or severe hypodysplasia and die within
24 hours after birth (Costantini and Shakya, 2006). The Ret receptor
isoforms containkey autophosphorylation sites in theC-terminal domain
(Airaksinen and Saarma, 2002; Borrello et al., 1996; Grimm et al., 2001;
Lorenzo et al., 1997). These can bind adaptors that recruit Grb2/Rasier).
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rights reserved.guanine exchange factor Sos complexes or the tyrosine phosphatase
Shp2 to the plasma membrane and activate downstream signaling cas-
cades like Erk/MAPK or others (Airaksinen and Saarma, 2002; Borrello
et al., 1996;Kurokawaet al., 2001).Both inactivatingandactivatingmuta-
tions in Ret cause renal agenesis in human fetuses (Skinner et al., 2008).
Ret signaling stimulated by GDNF leads to upregulated expression of
Ret andWnt11 in the tips of the ureteric bud (Pepicelli et al., 1997). GDNF
also upregulates the expression of the transcription factors Etv4 and Etv5
(Lu et al., 2009). Etv4 and Etv5 exhibit expression patterns similar to the
one of Ret. Mice that aremutant for both transcription factors show renal
agenesis. Studies of Sprouty1 knockout mice revealed supernumerary
ureteric buds, multiple ureters and multiplex kidneys, and thus showed
that Sprouty1 acts as a negative regulator of GDNF/Ret signaling (Basson
et al., 2005, 2006). Mice that are conditional mutants for the adaptor
Frs2α in the kidney show reduced kidney branching (Sims-Lucas et al.,
2009). Ret is not the only receptor tyrosine kinase that drives growth
and branching of the ureteric bud. FGFs have a stimulating effect on kid-
ney branching in vitro (Qiao et al., 2001) and FGF7 as well as FGF10 null
mice exhibit smaller kidneys (Ohuchi et al., 2000; Qiao et al., 1999). For a
role of Met and EGFR see Ishibe et al. (2009).
The tyrosine phosphatase Shp2 is a ubiquitously expressed enzyme
conserved between invertebrates and vertebrates that acts down-
stream of various growth factors, hormones or cytokines, and their
receptors (Neel et al., 2003). Mild gain- or loss-of-function mutations





























































Fig. 1. Kidney development in Hoxb7/Cre; Shp2ﬂ/ﬂ mice. (A, B) The kidneys and urogenital systems of control female (A) and mutant male (B) newborn mice are shown (arrows
point to mutant kidneys). (C, D) HE stained section of mutant and control kidneys at P0 (C, cortex; M, medulla and N, nephrogenic zone). (E) Mean value of glomeruli on sections of
the pelvic region of mutant and control kidneys. Mutant kidneys, n=3; sections n=4; control kidneys, n=2; sections, n=3. Standard deviations are indicated. (F, G) The kidney
epithelia at E15.5 were stained by anti-E-cadherin immunoﬂuorescence. (H-J) The branching of ureteric bud in whole mount E13.5 kidneys was visualized by anti-pan-cytokeratin
immunohistochemistry. Mean value of ureteric bud tips of control and mutant E13.5 kidneys (n=3).
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Loss-of-function mutations of Shp2 in mice lead to early embryonic
lethality (Yang et al., 2006). Conditional mutant mice have shown that
Shp2 is crucial in the development of the central nervous system, neural
crest cells, the heart or the mammary gland (Grossmann et al., 2010).
Shp2 is recruited to receptor tyrosine kinases directly (Tomic et al.,
1995) or indirectly through adaptors like IRS, Frs2α and Gab1 (Hadari
et al., 1998; Kuhne et al., 1993; Perrinjaquet et al., 2010; Schaeper et
al., 2000). Shp2 binds to receptors through its N-terminal SH2-
domains. Binding of the SH2-domains induces a conversion of the
closed inactive into an open active Shp2 structure. Shp2 promotes the
sustained activation of Ras and the downstream Erk/MAP kinases, but
can also activate the JAK/Stat, the PI3K and other pathways (Grossmann
et al., 2010; Neel et al., 2003). Components that are dephosphorylatedby Shp2 are the EGFR, Gab1, IRS1, RasGAP, or Paxillin. Shp2 can also
dephosphorylate and inactivate Sprouty (Jarvis et al., 2006).Materials and Methods
Mice
Conditional Shp2 mice that are mutant in the embryonic kidney
were generated by breeding Shp2ﬂ/ﬂ females to Hoxb7/Cre; Shp2ﬂ/+
males. Genotyping of mutant micewas performed as described (Basson
et al., 2006; Grossmann et al., 2009). To obtain compound mutants,
Shp2ﬂ/ﬂ; Spry1+/− females were crossed to Hoxb7/Cre; Shp2ﬂ/+;


















312 R. Willecke et al. / Developmental Biology 360 (2011) 310–317
313R. Willecke et al. / Developmental Biology 360 (2011) 310–317Organ cultures of embryonic kidneys
Kidneys were isolated from E11.5 embryos in ice-cold CO2-
independent medium (Gibco) and cultured at 37 °C in a humidiﬁed at-
mosphere on transwell ﬁlters (Costar) in DMEM (Gibco) with 10% FCS,
100U/ml penicillin and streptomycin. GDNF (rhGDNF) was obtained
from R&D Systems (Minneapolis, MN).
In situ hybridization, histopathology and immunohistochemistry
Tissue was ﬁxed overnight in 4% formaldehyde in PBS at 4 °C. In
situ hybridization was carried out on 8 μm parafﬁn sections or on
whole kidneys, as modiﬁed from published protocols (Wilkinson,
1998). Parafﬁn sections were stained with hematoxylin and eosin
(HE). Immunohistochemistry was performed on parafﬁn sections.
For determining the mitotic index by immunoﬂuorescence, ureteric
bud cells were labeled with an anti-pan cytokeratin antibody
(Sigma), mitotic cells with anti-phospho-histone 3 antibody, and
nuclei with DAPI (Sigma). Immunohistochemistry for pErk1/2 was
performed with a pErk1/2 antibody (Cell Signaling). For whole-
mount staining, embryonic kidneys were ﬁxed in 4% formaldehyde,
bleached in 7% H2O2 and postﬁxed in 4% formaldehyde. Kidneys
were incubated overnight with anti-pan-cytokeratin (Sigma) or
anti-E-cadherin (BD) antibodies, and overnight with secondary anti-
body and cleared in 80% glycerol/PBS.
Results and Discussion
Deletion of Shp2 in ureteric bud epithelia results in severe dysgenesis of
kidneys and ureters, and in downregulation of Ret target genes
We had generated a ﬂoxed Shp2 allele in mice (Shp2ﬂ, Suppl. Fig.
1A-C), which upon Cre-induced recombination deletes the essential
exons 3 and 4 of the Shp2 gene and produces a functional null allele,
Shp2del (Grossmann et al., 2009). To delete Shp2 conditionally in the
ureteric bud, we used the Hoxb7/Cre transgene, which drives Cre
expression in the Wolfﬁan duct and ureteric bud epithelium from
E9.5 onwards (Kress et al., 1990; Zhao et al., 2004). Indeed, the pres-
ence of Hoxb7/Cre deleted Shp2 speciﬁcally in the Wolfﬁan duct epi-
thelium and its derivatives (Suppl. Fig. 1D). Hoxb7/Cre; Shp2ﬂ/ﬂ mice
(called conditional Shp2mutants) were born at the expected Mende-
lian ratios but died within the ﬁrst 24 hours. Dissection of the urogen-
ital tracts of newborn mice showed that mutants had only
rudimentary kidneys (Fig. 1A, B, arrows), which were occasionally ac-
companied by hydroureters, indicating that the newborn mice may
die of renal failure. The kidneys of mutants lacked cortex and medulla
(Fig. 1C, D), consisted of undeﬁned parenchyma, and had reduced
numbers of tubules and glomeruli (quantiﬁed in Fig. 1E). This pheno-
type was fully penetrant. Immunoﬂuorescence staining of the kidneys
of E15.5 control animals with an anti-E-cadherin antibody revealed
organized branch tips at the periphery. In contrast, a disorganized
array of branch tips and nephrons as well as highly reduced sizes
were observed in mutant kidneys (Fig. 1F, G). Anti-pan-cytokeratin
antibody staining at E13.5 showed a drastic reduction in ureteric tip
numbers in Shp2 mutants (Fig. 1H, I; quantiﬁcation in J). In situ hy-
bridization on sections of kidneys at E11.5, a time point at which
the phenotype was not visible, showed that the Ret target genes
Etv4 (Lu et al., 2009) and Wnt11 (Majumdar et al., 2003) were
expressed in the ureteric bud tip cells of the mutant kidneys
(Fig. 2A-D). At E12.5, we could observe a severe downregulation ofFig. 2. Ret target gene expression in ureteric bud tips in Shp2mutant kidneys. (A-D) In situhybr
(E-J) In situ hybridization on parafﬁn sections. Etv4, Etv5 andWnt11 expression was downregu
unchanged in the metanephric mesenchyme. Arrows in F, H point to ureteric bud tips. The dot
bud tips of control and Shp2mutants at E12.5.the transcription factors Etv4 and Etv5 as well as the Ret target gene
Wnt11 (Fig. 2E-J). However, Ret expression was not altered in the
ureteric bud tips at E12.5 (Fig. 2K, L).
The kidney phenotype of the conditional Shp2 mutation is thus an
attenuated form of the phenotypes observed in Ret−/−, GDNF−/− and
GFRα-1−/− mice (Costantini and Shakya, 2006). We cannot exclude
that the attenuated phenotype is in part due to the fact that some
Shp2 protein remains in the ureteric bud tips, either because some
cells have escaped recombination and that non-recombined cells pref-
erentially form the branching epithelia, similar to what was previously
observed in chimeric Wolfﬁan ducts that consisted of Ret−/− and wild-
type cells (Shakya et al., 2005; Chi et al., 2009;). A further mechanism
might be based on the biochemical function of Shp2: Shp2 is necessary
for the sustained activation of receptor tyrosine pathways but not for
the initial signal (Jarvis et al., 2006). The result could therefore be a phe-
notype that is not equally severe as in Ret−/− and GDNF−/− mice. Our
Shp2 phenotype is actually similar to the one of mice that harbor a
hypopmorphic Ret mutation, the mutation of Y1062 of Ret9 on a Ret9
mono-isoformic background (Jain et al., 2006; Wong et al., 2005).
Thus overall, Shp2 appears to act downstream of GDNF/Ret, and
upstream of the Etv4/Etv5 transcription factors in kidney development.
Shp2 mutant kidneys undergo reduced branching in organ culture and
cannot be stimulated with GDNF
Hoxb7/Cre includes an EGFP reporter gene, and the development of
the kidneys can therefore be followed in organ culture (Zhao et al.,
2004). Kidney anlagen were explanted at E11.5, at which stage wild-
type and mutant ureteric buds were similar, i.e., had two tips. After
12 h of culture, a difference between control and mutant explants
was visible. The wildtype had undergone three rounds of branching
whereas the mutant exhibited only two branch generations (Fig. 3A,
insets in Fig. 3A; distinct branch generations are marked by different
colors). Ampullae of the mutants were generally smaller than in the
wildtype (Fig. 3A, arrows). After another day of culture, the branching
defect of the Shp2 mutant explants remained, as it showed only three
branch generations versus four generations in the wiltype explants.
Cell proliferation at the ureteric tips was measured by visualizing
mitotic cells with anti-phospho-histone 3 antibody immunoﬂuores-
cence, and total ureteric bud epithelial cells with anti-pan-cytokeratin
antibody staining on sections of E12.5 kidneys (n=13). Ureteric bud
epithelium was identiﬁed by pan-cytokeratin staining, and tips were
identiﬁed by their localization at the kidney periphery. Control ure-
teric bud tips exhibited 4.3% mitotic cells, and the mutant tips only
1.6% (Fig. 3C-E). This difference was statistically signiﬁcant (χ2-test
p=0.0104). Branching was also analyzed in the presence or absence
of exogenous GDNF. When stimulated with GDNF, a ten-fold increase
in the number of branch tips was observed in wildtype kidneys within
three days of culture, which was reduced by 25% in the absence of the
growth factor (Fig. 3H). In contrast, conditionalmutant kidneys showed
no sign of branching, in the presence or absence of GDNF (Fig. 3I).
Organ culture thus corroborates that Shp2 acts downstream of
GDNF/Ret signaling in kidney branching morphogenesis. Furthermore,
we observed a reduction of Erk/MAPK signaling in Shp2 deﬁcient ure-
teric bud tips (Fig. 3F, G). It has been demonstrated that Erk/MAPK sig-
naling downstream of many receptor tyrosine kinases is controlled by
Shp2 (Feng, 2007; Grossmann et al., 2010; Neel et al., 2003; Rosario
and Birchmeier, 2003). In particular, Shp2 promotes the sustained acti-
vation of Ras and of the downstream Erk/MAP kinases (Allard et al.,
1996; O'Reilly and Neel, 1998; Perkins et al., 1992; Tang et al., 1995).idization on parafﬁn section shows Etv4 andWnt11 expression in the ureteric bud at E11.5.
lated in Shp2mutant bud tips at E12.5. Note that the expression of Etv4 and Etv5 remain







































































Fig. 3. Branching morphogenesis in organ culture and sensitivity to GDNF. (A) GFP-expressing explants of control and Shp2mutant kidneys after 12 and 36 hours of organ culture.
White arrows point to ampullae of the branching tree. Stick ﬁgures (inlays), branch generation 1 in blue, 2 in yellow, 3 in red, 4 in white and 5 in blue. Scale bar, 1 mm. (B) Quan-
tiﬁcation of control (grey bar) and mutant (black bar) ureteric bud tips after 12 and 36 hours. Standard deviations are indicated. (C, D) Sections of E12.5 kidneys show proliferating
cells (anti-phospho-histone 3 staining, red) and non-proliferating cells (anti-cytokeratin staining, green) of the ureteric buds. Ureteric bud tips were identiﬁed by their location at
the kidney periphery. Renal vesicles are anti-pan-cytokeratin negative (white arrows) and could be excluded from the quantiﬁcation. (E) The total amount of mitotic epithelial tip
cells and the total amount of epithelial tip cells (570 cells) was counted on sections of Shp2mutants (n=2) and controls (n=3). Mitotic index, percentage of anti phospho-histone
3-positive cells in ureteric bud tips (χ2-test p=0.0104). (F, G) Sections of E12.5 kidneys show pErk1/2 in the ureteric bud tip of controls, staining is reduced in the Shp2 mutant
(arrows point to ureteric bud tips). (H, I) Quantiﬁcation of ureteric bud tips in kidney explants grown in the presence (grey curve) and absence (black curve) of 10 ng/ml of GDNF.
314 R. Willecke et al. / Developmental Biology 360 (2011) 310–317Moreover, in human diseases like Noonan syndrome, genes of the Ras
pathway including Shp2 are mutated (Grossmann et al., 2010). A strong
reduction of proliferationwas indeed seen at the branching bud tips andin ampullae in the mutant, consistent with reduced Erk/MAPK signal-
ing. Other reports linked Shp2 to the regulation of PI3K/Akt and JAK/
Stat signaling (Besset et al., 2000; Fisher et al., 2001; Jain et al., 2006;
315R. Willecke et al. / Developmental Biology 360 (2011) 310–317Lu et al., 2009; Schuringa et al., 2001). The transcription factors Etv4 and
Etv5 are indispensable for transmission of Ret signals and are downre-
gulated in the Shp2mutants, and thismay occur via the PI3K/Akt signal-
ing, as indicated by chemical interference (Besset et al., 2000; Fisher et
al., 2001; Jain et al., 2006; Lu et al., 2009; Schuringa et al., 2001). How
Erk/MAPK and PI3K signaling might cooperate in kidney development
is not known.
Loss of Shp2 in the ureteric bud epithelium prevents multiple outgrowths
of the ureteric buds in Sprouty1 null mutants
We also examined Sprouty1 and Shp2 double mutant mice
(Sprouty1−/−; Hoxb7/Cre; Shp2ﬂ/ﬂ mutants, for genotyping see Suppl.
Fig. 1E). Surprisingly, the kidney morphologies of newborn compound
mutants were virtually identical to those of Shp2 single mutants (Fig. 4;
compare A, B and A′, B′). Whereas Sprouty1−/− animals exhibited large












Fig. 4. Branching morphogenesis in Shp2; Spry1 double mutants (A-D) Newborn kidneys an
of mutant and control kidneys of the indicated genotypes at P0. (A″-D″) Sections of E12.5 ksmall, composed of unorganized parenchyma and had a reduced number
of tubules (Fig. 4; compare A, C and A′, C′). We examined seven kidneys
of double mutants at P0; of these, six displayed a single ureter and a sin-
gle kidney, andone a duplex ureter and duplex kidney. In comparison, all
Sprouty1−/−mice displayed large, multiplex kidneys. Furthermore, two
of the double mutant kidneys showed hydronephrosis, usually caused
by urine reﬂux.
The kidney phenotype of compoundmutants of Shp2 and Sprouty1
mimics the one of single Shp2mutants. Instead of aberrant branching
of the ureteric bud tree in Sprouty1−/− mice, branching was strongly
reduced, and instead of multiple ureters, single ureters were seen. In
contrast, ablation of Sprouty1 rescued kidney development of Ret−/−
or GDNF−/− mice, but could not rescue kidney development in
GDNF−/−; FGF10−/− double mutants (Michos et al., 2010). This indi-
cates that in the absence of GDNF and Sprouty1, FGF10 and other
growth factor signaling sufﬁces to drive epithelial branching of the




d urogenital tracts with the indicated genotypes are shown. (A′-D′) HE stained sections
idneys are shown. White arrows show single ureteric buds in A″ and D″.
316 R. Willecke et al. / Developmental Biology 360 (2011) 310–317upstream of Sprouty1 in the ureteric bud, the lack of Sprouty1 should
have rescued kidney development in Shp2 mutant mice. The lack of
rescue in the Sprouty1; Shp2 double mutant therefore suggests a
model in which Shp2 acts downstream of Sprouty1 in the GDNF/Ret
signalling cascade. It cannot be excluded that Shp2 acts also in other
receptor signaling pathways in kidney development. However, it
has been shown that Sprouty1 can associate with Shp2 in cultured
cells, which dephosphorylate an essential tyrosine residue and by
this inactivates Sprouty1 (Hanafusa et al., 2004; Jarvis et al., 2006).
The molecular interaction between Sprouty1 and Shp2 in kidney de-
velopment needs to be further addressed.
Conclusions
Our data show that the tyrosine phosphatase Shp2 functions in
ureteric bud epithelial cells and plays an essential role in branching
morphogenesis of early kidney development. Shp2 acts downstream
of the Ret receptor, which we could validate by the downregulation
of the Ret target genes Etv4, Etv5 andWnt11 in Shp2 deﬁcient ureteric
bud epithelia, and by GDNF stimulation experiments in organ culture.
Furthermore, Shp2 conditional mutant kidneys exhibit a lower prolif-
eration rate and a reduced Erk1/2 activation. Thus, Shp2 is critical to
mediate Ret driven Erk/MAPK signaling for the regulation of ureteric
bud branching morphogenesis during kidney development.
Supplementary materials related to this article can be found on-
line at doi:10.1016/j.ydbio.2011.09.029.
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